Cold & Cough Remedies (Pharmacies) - Japan

Revenue in the Cold & Cough Remedies market is projected to reach US$1.04bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.97%, resulting in a market volume of US$1.32bn by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$8.45 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Japan is experiencing steady growth due to several factors.

Customer preferences: Japanese consumers have a strong preference for over-the-counter remedies for cold and cough symptoms. They value convenience and accessibility, and prefer to purchase such products from local pharmacies. This preference for pharmacies is driven by the trust and reliability associated with these establishments, as well as the availability of knowledgeable pharmacists who can provide advice and recommendations.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in Japan is the increasing demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived as being safer and more gentle on the body. This has led to a rise in the popularity of traditional Japanese herbal remedies, such as kampo medicine, which are believed to have fewer side effects compared to conventional pharmaceuticals. Another trend in the market is the growing demand for combination products that offer multiple benefits. Consumers are looking for remedies that not only relieve cold and cough symptoms, but also provide additional benefits such as boosting the immune system or soothing a sore throat. Manufacturers are responding to this demand by developing products that combine different active ingredients to address multiple symptoms.

Local special circumstances: Japan has a high population density, with many people living in urban areas. This concentration of population creates a favorable environment for the growth of pharmacies, as there is a large customer base in close proximity to these establishments. Additionally, the aging population in Japan has contributed to the growth of the Cold & Cough Remedies market, as older individuals are more susceptible to cold and cough symptoms and are likely to seek remedies to alleviate their discomfort.

Underlying macroeconomic factors: The Japanese economy has been experiencing slow but steady growth in recent years. This has led to an increase in disposable income among consumers, allowing them to spend more on healthcare products, including cold and cough remedies. Furthermore, the government has been implementing policies to promote the use of generic drugs, which has made healthcare more affordable for consumers and has contributed to the growth of the Cold & Cough Remedies market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Japan is growing due to customer preferences for over-the-counter remedies, the demand for natural and combination products, the concentration of population in urban areas, the aging population, the steady economic growth, and government policies promoting affordable healthcare. These factors are driving the development and expansion of the market in Japan.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.